Latest News about Clinical trials
Recent news which mentions Clinical trials
Cures Within Reach Receives Grant from Chan Zuckerberg Initiative to Fund Clinical Trials that Validate AI-Generated Drug-Disease Repurposing Matches
December 17, 2024
From PRLog
From Benzinga
From PRLog
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
December 01, 2023
From CNBC.com News
Wegovy could prevent up to 1.5 million heart attacks, strokes over 10 years, study says
August 16, 2023
From CNBC.com News
From PRLog
Bright Mind Shares Surge 91% After Reporting Positive EEG Clinical Results Of Next-Gen Compound
August 08, 2023
Tickers
DRUG
From Benzinga
Eli Lilly says obesity drug helped boost weight loss to 26%, highest seen in late-stage trials
July 27, 2023
From CNBC.com News
From CNBC.com News
Fully recruited EPIC-Skin international study for the treatment of Non-Melanoma Skin Cancer
July 11, 2023
Tickers
EPIC
From PRLog
From PRLog
What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways
January 03, 2023
From Benzinga
Analyzing Psychedelics & Traditional Pharma Interaction: New Clinical Trial Begins Dosing
December 19, 2022
Tickers
DMTTF
From Benzinga
Psychedelics And Treatment-Resistant Depression: COMPASS Pathways Replies To Comments
December 09, 2022
Tickers
CMPS
From Benzinga
One of North Carolina's Largest Charitable Clinics First in State to Offer Clinical Trials as A Care Option to Patients
November 29, 2022
From PRLog
Atai Life Sciences' Q3 2022 Financials & Business Update, 'Strong Capability To Execute'
November 10, 2022
Tickers
ATAI
From Benzinga
Medtronic Podcast: Dr. Laura Mauri Brings Years of Patient Care Experience to Medtronic’s Top Clinical, Regulatory, Scientific Post
August 10, 2022
Tickers
MDT
Results of Pivotal SafeBreak® Vascular Clinical Study Published in Journal of Infusion Nursing
March 23, 2022
From PRLog
aiaTranslations Receives ISO 17100 Certification
February 17, 2022
From PRLog
The at-home testing industry, from Covid to cancer, may be worth over $2 billion by 2025
February 03, 2022
Tickers
CEO
From CNBC.com News
From PRUnderground
From CNBC.com News